“…Whilst the exact mechanisms whereby CARPs exert their neuroprotective effects are still being explored, there is increasing evidence that this class of peptides possess properties that can impart multiple potential beneficial effects following acute brain injuries such HIE and stroke. For example, CARPs have the capacity to mitigate excitotoxicity (Edwards et al, ; Edwards, Anderton, Knuckey, & Meloni, ; Meloni et al, ; Meloni, Milani, et al, ), reduce intracellular and mitochondrial calcium influx (Edwards et al, ; ; Marshall et al, ; Meloni, Milani, et al, ; Rigobello, Barzon, Marin, & Bindoli, ), reduce cell surface levels of ion channels (Brittain et al, ; Brustovetsky, Pellman, Yang, Khanna, & Brustovetsky, ; MacDougall, Anderton, Edwards, Knuckey, & Meloni, ; Sinai, Duffy, & Roder, ) and TNF receptors (Fotin‐Mleczek et al, ), assist in maintaining mitochondrial integrity (Birk, Chao, Liu, Soong, & Szeto, ; Cerrato, Pirisinu, Vlachos, & Langel, ; Ferré et al, ; Marshall et al, ; Rigobello et al, ; Szelechowski et al, ; Szeto et al, ; Zhao et al, ), inhibit the activity of the proteasome and matrix metalloproteinases (Anbanandam, Albarado, Tirziu, Simons, & Veeraraghavan, ; Cameron, Appel, Houghten, & Lindberg, ; Fugere, Appel, Houghten, Lindberg, & Day, ; Gaczynska, Osmulski, Gao, Post, & Simons, ; Kacprzak et al, ), reduce lipid peroxidation and oxidative stress and modulate immune responses and activate pro‐survival signalling (Cook et al, ; Yang et al, ).…”